Clinical Trial Update: Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cholestyramine and prednisolone as adjunctive therapy for overt hyperthyroidism, including Graves disease, with unknown curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Hyperthyroidism

Drugs mentioned

• Cholestyramine (cholestyramine)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Clinical Research Centre, Malaysia | Conditions: Hyperthyroidism, Graves Disease | Phase 3 | Status: UNKNOWN